Pivonello, Claudia
Patalano, Roberta
Solari, Domenico
Auriemma, Renata S.
Frio, Federico
Vitulli, Francesca
Grasso, Ludovica F. S.
Di Cera, Marialuisa
De Martino, Maria Cristina
Cavallo, Luigi M.
Cappabianca, Paolo
Colao, Annamaria
Pivonello, Rosario
Funding for this research was provided by:
Novartis Pharma
Article History
Received: 8 May 2017
Accepted: 2 July 2018
First Online: 31 July 2018
Compliance with ethical standards
:
: A.C. has been principal investigator of research studies from Novartis, Ipsen, Pfizer and Lilly, has received research grants from Ferring, Lilly, Ipsen, Merck-Serono, Novartis, Novo-Nordisk and Pfizer, has been occasional consultant for Novartis, Ipsen and Pfizer, and has received fees and honoraria from Ipsen, Novartis, and Pfizer. R.P. has been principal investigator of research studies from Novartis and HRA Pharma, has received research grants from Novartis, Ipsen, Pfizer, Viropharma and IBSA, has been occasional consultant for Novartis, Ipsen, Pfizer, Viropharma, Ferring and Italfarmaco, and received lecture fees and honoraria from Novartis, Pfizer and Shire. The remaining authors declare that they have no conflict of interest.
: All procedures performed in this study were in accordance with the ethical standards of the University Federico II of Naples (Naples, Italy) and with the 1964 Helsinki declaration and its later amendments.
: Informed consent was obtained from each patient.